MedTrace Logo

Possible Augmentation Of NB-UVB Induced Pigmentation In NSV By Carboxy.

NCT07563049 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2026-05-01

No results posted yet for this study

Summary

Patients with stable vitiligo with 2 or more symmetric patches, 2 on acral sites and/or 2 on non acral sites will be recruited and assessed for eligibility for inclusion to receive NB-UVB on the whole body, and carboxytherapy on one randomized side.

Conditions

  • Vitiligo Vulgaris

Interventions

DEVICE

NB-UVB alone

Narrow-Band Ultraviolet B phototherapy full cabin

DEVICE

NB-UVB combined with carboxy

Narrow-Band Ultraviolet B phototherapy full cabin combined with Intradermal injection of carbon dioxide gas

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-15
Primary Completion
2025-12-22
Completion
2026-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07563049 on ClinicalTrials.gov